ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Feasibility of Regulatory T Cell Cryopreservation and Banking for Clinical Therapeutic Applications

K. Gołąb,1 O. Savari,1 S. Ramachandran,1 Z. Tekin,1 M. Tibudan,1 J. Millis,1 P. Trzonkowski,2 P. Witkowski.1

1Surgery, University of Chicago, Chicago, IL
2Immunology, Medical University of Gdansk, Gdansk, Poland.

Meeting: 2015 American Transplant Congress

Abstract number: A259

Keywords: CD4, T cells, Tolerance

Session Information

Date: Saturday, May 2, 2015

Session Name: Poster Session A: Preclinical Immunosuppression and Tolerance

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Related Abstracts
  • Mature Dendritic Cells Are Superior Stimulator Cells for Expansion of Human Alloreactive Regulatory T Cells
  • Generation, Cryopreservation, Function and In Vivo Fate of Ex-Vivo Expanded Cynomolgus

Feasibility of clinical application of regulatory T cells (Tregs) in clinical transplantation would be improved if Tregs or pre-enriched cells for Treg isolation could be cryopreserved until the right time for infusion. In this study we tested two strategies: 1) cryopreservation of CD4+ cells for Treg isolation/expansion and 2) cryopreservation of already expanded Tregs followed by another expansion.

Human CD4+ cells were isolated from leukapheresis products, frozen and kept in liquid nitrogen. After 1 year, cells were thawed and cultured overnight. Cell viability/apoptosis and expression of CD25, CD127, FoxP3 markers were checked. Next, Tregs were sorted and expanded for 13 days. Suppression of proliferation assay was performed at the end of expansion.

Another portion of fresh CD4+ cells was used directly to sort and expand Tregs. Cells were cryopreserved after expansion and stored for 1 year. Then, they were processed in the same way as CD4+ cells for thawing and expanded again.

Results. The average cell recovery was 76% and 32% just after thawing, but decreased to 38% and 8% after overnight culture for CD4+ and Treg cells, respectively. That might be related to 25% of CD4+ cells and 55% of Tregs indicated apoptosis/necrosis. The mean % of CD25hiCD127- cells in fresh CD4+ cells was 7.13% and decreased to 5.86% after thawing. Also, mean % of FoxP3+ cells decreased from 7.1% to 6%. After o/n culture, these proportions increased to 6.82% and 9.47%, respectively. After Treg thawing % of CD25hiCD127- cells decreased from 97.4% to 67.2%. No change was observed in % of FoxP3+ (>75%). However, after o/n culture % of CD25hiCD127- and FoxP3+ cells decreased to 42.9% and 46.4%, respectively. Tregs obtained after sorting from thawed CD4 cell expanded well, but failed to present in vitro suppressive abilities in contrast to thawed Tregs after their expansion.

Conclusion. Tregs obtained from cryopreserved CD4+ cells didn't show suppressive properties, which might be related to instability of key Treg markers upon cryopreservation and subsequent inability to sort pure cells. In contrast, cryopreserved Tregs after expansion demonstrated suppressive abilities. These results indicate that expanded Tregs can be cryopreserved and used again as therapy product upon stimulation and expansion to overcome cell loss and instability of their markers.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gołąb K, Savari O, Ramachandran S, Tekin Z, Tibudan M, Millis J, Trzonkowski P, Witkowski P. Feasibility of Regulatory T Cell Cryopreservation and Banking for Clinical Therapeutic Applications [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/feasibility-of-regulatory-t-cell-cryopreservation-and-banking-for-clinical-therapeutic-applications/. Accessed April 20, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.